Dec. 2006/Jan. 2007 | Affymetrix and Iconix Biosciences have announced the launch of the ToxFX Analysis Suite, a toxicogenomics solution designed to improve researchers’ understanding of safety issues associated with drug candidates, compounds, or environmental toxicants. ToxFX combines Iconix’ automated analysis with Affymetrix’ GeneChip arrays, and helps scientists prioritize drug candidates and make preclinical development decisions. The software generates a safety profile that can diagnose or predict 50 toxicological outcomes and examine gene expression changes.
Product: ToxFX Analysis Suite
Company: Affymetrix and Iconix Biosciences
For more information: www.affymetrix.com, www.iconixbiosciences.com